SUMMARYThe aim of this study was to assess the long term efficacy of DDD pacing mode in selected patients with idiopathic dilated cardiomyopathy (IDCM) and drug refractory heart failure. The patients were evaluated according to the long term alteration of the sympathovagal balance (SVB). Patients with IDCM were considered eligible for DDD pacing if during temporary VDD pacing a 15% or more increase in the resting cardiac output was demonstrated. From the 29 patients studied, finally 20 patients (15M, 5F, 69 ± 10 years) fulfilled the aforementioned criterion and therefore were considered candidates for permanent DDD pacing (NYHA class: 3.5 ± 0.3, Ejection fraction : 27 ± 7%, Resting cardiac index (CI) 2.6 ± 0.4 l / min). The ECG of the patients demonstrated LBBB in 13, RBBB in 4 and RBBB + LAH in 3, with a PR interval of 232 ± 28 ms and QRS duration of 138 ± 15ms. The pacemaker was programmed at 40-150 bpm, and AV delay of 105 ± 20 ms. The lower heart rate programmed, in conjunction with the heart failure state of these patients, was responsible for essentially continuous atrial tracking, ventricular pacing. We evaluated the SVB in the pre-and post-implant periods (3rd and 6th month), using the hourly power spectral analysis (PSA) of heart rate variability during 24 hour Holter monitoring. As SVB we considered the ratio: low (0.04 -0.15 Hz) to high frequency (0.15 -0.40 Hz). We compared the SVB (LF / HF) during the day and night time for the pre-and post-implant periods. Post-pacing, the NYHA class was significantly improved (2.9 ± 0.2 and 2.7 ± 0.3 the 3rd and 6th month respectively). The mean heart rate was 78 ± 8 bpm in the 3rd and 80 ± 7 bpm in the 6th month postoperatively, which was lower than the 84 ± 9 bpm preoperatively, but this difference did not reach statistical significance. During